Scalper1 News
Persistence paid off for big pharma AbbVie (ABBV) Friday as it announced a takeover agreement with Shire (SHPG) after its fifth attempt. At the same time, Shire reported its Q2 earnings ahead of schedule, with results that beat analyst estimates. The basic terms of the deal were the same as Monday’s revised offer: 24.44 British pounds plus 0.8960 shares of the combined company for each Shire share. Based on AbbVie’s Thursday closing price, the Scalper1 News
Scalper1 News